Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report)’s stock price was up 1.3% during mid-day trading on Tuesday . The stock traded as high as $2.45 and last traded at $2.37. Approximately 7,693 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 842,200 shares. The stock had previously closed at $2.34.
Ampliphi Biosciences Stock Performance
About Ampliphi Biosciences
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Featured Stories
- Five stocks we like better than Ampliphi Biosciences
- How to Invest in Small Cap Stocks
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Lowe’s Stock: Hold Now, Buy it When it Dips
- Business Services Stocks Investing
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
